BR112012031102A2 - forma de dosagem oral sólida - Google Patents

forma de dosagem oral sólida

Info

Publication number
BR112012031102A2
BR112012031102A2 BR112012031102A BR112012031102A BR112012031102A2 BR 112012031102 A2 BR112012031102 A2 BR 112012031102A2 BR 112012031102 A BR112012031102 A BR 112012031102A BR 112012031102 A BR112012031102 A BR 112012031102A BR 112012031102 A2 BR112012031102 A2 BR 112012031102A2
Authority
BR
Brazil
Prior art keywords
dosage form
oral dosage
solid oral
solid
oral
Prior art date
Application number
BR112012031102A
Other languages
English (en)
Other versions
BR112012031102B1 (pt
BR112012031102B8 (pt
Inventor
Bharat Pravinchandra Mehta
Manoj Kantilal Patel
Parmeshwar B Bang
Rajen Dhirubhai Shah
Original Assignee
J B Chemicals And Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J B Chemicals And Pharmaceuticals Ltd filed Critical J B Chemicals And Pharmaceuticals Ltd
Publication of BR112012031102A2 publication Critical patent/BR112012031102A2/pt
Publication of BR112012031102B1 publication Critical patent/BR112012031102B1/pt
Publication of BR112012031102B8 publication Critical patent/BR112012031102B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112012031102A 2010-09-16 2010-12-01 forma de dosagem oral sólida BR112012031102B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2564MU2010 2010-09-16
IN2564/MUM/2010 2010-09-16
PCT/IN2010/000775 WO2012035541A1 (en) 2010-09-16 2010-12-01 Nicotine containing formulation

Publications (3)

Publication Number Publication Date
BR112012031102A2 true BR112012031102A2 (pt) 2015-09-22
BR112012031102B1 BR112012031102B1 (pt) 2021-05-18
BR112012031102B8 BR112012031102B8 (pt) 2021-05-25

Family

ID=45831078

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031102A BR112012031102B8 (pt) 2010-09-16 2010-12-01 forma de dosagem oral sólida

Country Status (10)

Country Link
US (1) US9180124B2 (pt)
EP (1) EP2496083A4 (pt)
AU (1) AU2010360967B2 (pt)
BR (1) BR112012031102B8 (pt)
CA (1) CA2782734C (pt)
EA (1) EA025779B1 (pt)
MX (1) MX339470B (pt)
UA (1) UA112974C2 (pt)
WO (1) WO2012035541A1 (pt)
ZA (1) ZA201206589B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
ES2471665B1 (es) * 2012-12-21 2015-03-12 Farmalider Sa Producto sustitutivo del tabaco
WO2015136124A1 (es) * 2014-03-11 2015-09-17 Farmalider, S.A. Producto sustitutivo del tabaco
CN111226941B (zh) * 2020-02-15 2021-08-20 浙江大学 一种防治作物害虫的植物源杀虫剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
ES2206709T3 (es) 1996-05-13 2004-05-16 Novartis Consumer Health S.A. Sistema de suministro bucal.
CN101301275A (zh) * 2001-03-26 2008-11-12 史密丝克莱恩比彻姆公司 含烟碱的口服剂量形式的制备方法
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20040107971A1 (en) * 2002-09-17 2004-06-10 Abhijit De Gum based chewing product and process for preparing the same
KR20050096922A (ko) * 2002-12-20 2005-10-06 니코노범 에이비 물리적 및 화학적으로 안정된 니코틴 함유 입자물질
DE102005058569B4 (de) 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
ITTV20060039A1 (it) 2006-03-14 2007-09-15 Nice Spa Sistema di controllo per uno o piu' azionamenti.
US20090214442A1 (en) 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
US20100124560A1 (en) 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof

Also Published As

Publication number Publication date
ZA201206589B (en) 2014-02-26
AU2010360967B2 (en) 2015-08-20
CA2782734A1 (en) 2012-03-22
MX2012012973A (es) 2013-03-05
MX339470B (es) 2016-05-27
EA201390394A1 (ru) 2013-07-30
BR112012031102B1 (pt) 2021-05-18
EP2496083A4 (en) 2013-05-01
EA025779B1 (ru) 2017-01-30
US9180124B2 (en) 2015-11-10
WO2012035541A1 (en) 2012-03-22
CA2782734C (en) 2018-03-27
EP2496083A1 (en) 2012-09-12
BR112012031102B8 (pt) 2021-05-25
UA112974C2 (uk) 2016-11-25
AU2010360967A1 (en) 2012-07-05
US20120244104A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
BR112013014361A2 (pt) forma de dosagem
SMT201700008B (it) Composizione farmaceutica
BRPI1008023A2 (pt) forma de dosagem sólida
SMT201600350B (it) Composizioni farmaceutiche
BR112012028549A2 (pt) escova de dentes
DK3246018T3 (da) Farmaceutisk sammensætning
IT1394860B1 (it) Composti farmaceutici
BR112014006689A2 (pt) composição de cuidado oral
BR112013011850A2 (pt) escova de dentes
EE201300005A (et) Ravimkoostis
CR20130380A (es) Tableta dispensable en forma oral
BR112012031102A2 (pt) forma de dosagem oral sólida
SI2645992T1 (sl) Trdna oralna dozirna oblika z asimetrično obliko
DK2613888T3 (da) Doseringsanordning
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
CO6801722A2 (es) Composiciones farmacéuticas
BR112013008074A2 (pt) combinações farmacêuticas
DK2635269T3 (da) Kombinationspræparat
IT1393930B1 (it) Composti farmaceutici
CO6801778A2 (es) Composiciones de cuidado oral
BR112012022294A2 (pt) articulador
BR112013003275A2 (pt) composição de tratamento oral
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
IT1395724B1 (it) Composti farmaceutici
BR112013014673A2 (pt) composições orais

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A01N 43/40

Ipc: A61K 31/465 (2006.01), A61P 25/34 (2006.01)

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/12/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/12/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF